JPRN-UMIN000017077已完成未知
A randomised, comparative study of vonoprazan and esomeprazole 20mg in the treatment of gastric ulcers due to endoscopic submucosal dissection (ESD) for gastric mucosal cancer. - A randomised, comparative study of vonoprazan and esomeprazole 20mg in the treatment of gastric ulcers due to endoscopic submucosal dissection (ESD) for gastric mucosal cancer.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Hypersensitivity of esomeprazole and vonoprzan. 2.Taking medicine which are possible to interact with vonoprazan or esomeprazole. 3.under pregnancy or breast-feeding. 4.Impossibility of oral intake. 5.Past history of resection of upper GI tract.
研究者
相似试验
已完成
不适用
Clinical study comparing the effect of Vonoprazan, on the healing of endoscopic submucosal dissection-derived artificial ulcer with PPI : a case controlled study.JPRN-UMIN000021010Kagawa Prefectural Central Hospital75
招募中
不适用
A randomized controlled trial comparing Vonoprazan, Amoxicillin, Metronidazole triple therapy and Rabeprazole, Amoxicillin, Metronidazole triple therapy as a second-line eradication of Helicobacter pyloriHelicobacter pylori infectionJPRN-UMIN000025801Yokohama City University Hospital80
已完成
不适用
A randomized controlled trial comparing Vonoprazan, Amoxicillin and Metronidazole triple therapy and Vonoprazan, Amoxicillin and Clarithromycin triple therapy as a first-line eradication of Helicobacter pyloriHelicobacter pylori infectionJPRN-UMIN000025773Yokohama City University (Basic research expenditures)124
已完成
4 期
Randomized comparative trial of vonoprazan and esomeprazole in triple therapy for the eradication of Helicobacter pylori.Chronic gastritis with Helicobacter pylori infectionJPRN-UMIN000018654Takamatsu Redcross Hospital520
招募中
3 期
The effectiveness of Vonoprazan comparing with high dose proton pump inhibitor in recurrence bleeding rate of high risk peptic ulcer: A randomised controlled studyBleeding peptic ulcerProton pump inhibitor, Potassium competitive acid blocker, Peptic ulcer disease, Upper gastrointestinal bleeding, Vonoprazan, Mortality, RebleedingTCTR20210227002Faculty of Medicine, Prince of Songkhla University100